We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$632B
| $1.13B | 5.4% |
9,070,522
+6,682,389
| +280% | +$798M |
|
|
2
ExxonMobil
XOM
$650B
| $371M | 1.77% |
4,528,134
+2,258,247
| +99% | +$189M |
|
3
Apple
AAPL
$4.88T
| $343M | 1.64% |
9,539,144
-172,972
| -2% | -$5.7M |
|
|
4
Merck
MRK
$324B
| $237M | 1.13% |
3,905,826
+1,327,845
| +52% | +$80.6M |
|
5
Home Depot
HD
$329B
| $212M | 1.01% |
1,444,896
+23,506
| +2% | +$3.33M |
|
6
Microsoft
MSFT
$2.85T
| $211M | 1.01% |
3,208,901
-32,640
| -1% | -$2.09M |
|
|
7
PepsiCo
PEP
$186B
| $181M | 0.87% |
1,619,236
-513,715
| -24% | -$55.1M |
|
8
Accenture
ACN
$89B
| $170M | 0.81% |
1,421,414
+108,507
| +8% | +$13M |
|
9
Oracle
ORCL
$341B
| $170M | 0.81% |
3,810,726
-35,896
| -0.9% | -$1.49M |
|
10
JPMorgan Chase
JPM
$937B
| $164M | 0.78% |
1,866,537
-62,508
| -3% | -$5.51M |
|
11
Boeing
BA
$166B
| $156M | 0.75% |
884,447
+11,037
| +1% | +$1.88M |
|
12
Cisco
CSCO
$450B
| $152M | 0.72% |
4,485,597
-61,897
| -1% | -$2.01M |
|
13
Procter & Gamble
PG
$342B
| $151M | 0.72% |
1,681,682
-181,543
| -10% | -$16.1M |
|
14
Amgen
AMGN
$203B
| $151M | 0.72% |
918,458
-3,342
| -0.4% | -$555K |
|
15
Keurig Dr Pepper
KDP
$40.3B
| $143M | 0.69% |
1,464,770
+15,522
| +1% | +$1.45M |
|
16
TJX Companies
TJX
$171B
| $143M | 0.68% |
3,618,560
+852,892
| +31% | +$32.9M |
|
|
17
Cognizant
CTSH
$21.2B
| $137M | 0.66% |
2,307,502
+1,502,158
| +187% | +$86.4M |
|
|
VMW
18
DELISTED
VMware, Inc
VMW
| $135M | 0.65% |
1,469,155
-4,785
| -0.3% | -$421K |
|
19
Biogen
BIIB
$29.9B
| $135M | 0.65% |
494,448
+80,817
| +20% | +$22.9M |
|
20
Chevron
CVX
$388B
| $133M | 0.64% |
1,239,812
+6,545
| +0.5% | +$734K |
|
21
Omnicom Group
OMC
$22.6B
| $129M | 0.62% |
1,497,951
-100,140
| -6% | -$8.54M |
|
22
Lowe's Companies
LOW
$116B
| $125M | 0.6% |
1,523,410
+139,222
| +10% | +$10.7M |
|
23
3M
MMM
$88.2B
| $123M | 0.59% |
769,881
+2,911
| +0.4% | +$447K |
|
24
Meta Platforms (Facebook)
META
$1.53T
| $123M | 0.59% |
866,534
+123,671
| +17% | +$16.5M |
|
25
PayPal
PYPL
$49.6B
| $122M | 0.58% |
2,840,719
-24,003
| -0.8% | -$1M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.